Lucintel's latest market report analyzed that cell & gene therapy manufacturing service provides attractive opportunities in cell processing, cell banking, process development, fill & finish operations, analytical and quality testing, raw material testing, and vector production. The cell & gene therapy manufacturing service market is expected to reach $20.5 billion by 2028 with a CAGR of 22.1%. In this market, cell therapy is the largest segment by therapy type, whereas process development is largest by workflow.

Download Brochure of this report by clicking on https://www.lucintel.com/cell-and-gene-therapy-manufacturing-service-market.aspx

Based on therapy type, the cell & gene therapy manufacturing service market is segmented into cell therapy and gene therapy. The cell therapy segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to increasing adoption of this therapy in treating diseases, such as cancer, autoimmune, urinary, and infectious issues.

Browse in-depth TOC on “Cell &Gene Therapy Manufacturing Service Market”

100 – Figures/Tables

150 – Pages

The Cell &Gene Therapy Manufacturing Service Market is marked by the presence of several big and small players. Some of the prominent players offering cell & gene therapy manufacturing service include Lonza, Bluebird Bio, Catalent, Roche, and Samsung Biologics.

Request Sample Report:

https://www.lucintel.com/cell-and-gene-therapy-manufacturing-service-market.aspx

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.